IMPOWER130

NCT02367781 📎

Regimen

Experimental
atezo + carbo + nab-paclitaxel
Control
carbo + nab-paclitaxel

Population

1L non-sq NSCLC, EGFR/ALK-WT ITT

Key finding

mOS 18.6 vs 13.9 mo, HR 0.79 (0.64-0.98); 1L non-sq IO-chemo option

Source: PMID 31122901

Timeline

  • Enrollment start: 2015-04-16 📎

Guideline citations

  • NCCN NSCLC Version 5.2026 (p.113)
  • CSCO NSCLC 2025 ⚠️ OCR source